How many are affected? A real limit of epidemiology
- PMID: 20735844
- PMCID: PMC2936291
- DOI: 10.1186/1742-5573-7-6
How many are affected? A real limit of epidemiology
Abstract
A person can experience an effect on the occurrence of an outcome in a defined follow-up period without experiencing an effect on the risk of that outcome over the same period. Sufficient causes are sometimes used to deepen potential-outcome explanations of this phenomenon. In doing so, care should be taken to avoid tipping the balance between simplification and realism too far toward simplification. Death and other competing risks should not be assumed away. The time scale should be explicit, with specific times for the occurrence of specified component causes and for the completion of each sufficient cause. Component causes that affect risk should occur no later than the start of the risk period. Sufficient causes should be allowed to have component causes in common. When individuals experience all components of two or more sufficient causes, the outcome must be recurrent. In addition to effects on rates and risks, effects on incidence time itself should be considered.
Similar articles
-
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89. Res Rep Health Eff Inst. 2009. PMID: 19554969
-
"Just Another Statistic".Oncologist. 1998;3(3):III-IV. Oncologist. 1998. PMID: 10388105
-
Measures of effect based on the sufficient causes model. 2. Risks and rates of disease associated with a single preventive agent.Epidemiology. 1993 Nov;4(6):517-23. doi: 10.1097/00001648-199311000-00007. Epidemiology. 1993. PMID: 8268280
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
[Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].Clin Lab. 2014;60(4):S1-39. doi: 10.7754/clin.lab.2014.140210. Clin Lab. 2014. PMID: 24779310 Review. German.
Cited by
-
Author's response to Poole, C. Commentary: How Many Are Affected? A Real Limit of Epidemiology.Epidemiol Perspect Innov. 2010 Aug 26;7:7. doi: 10.1186/1742-5573-7-7. Epidemiol Perspect Innov. 2010. PMID: 20796296 Free PMC article. No abstract available.
References
-
- Wing S. Limits of epidemiology. Med Global Surv. 1994;1:74–86.
-
- Bunton R, Russell J. The limits to epidemiology revisited. Crit Public Health. 1997;7:2–6. doi: 10.1080/09581599708409074. - DOI
Publication types
LinkOut - more resources
Full Text Sources